Original insights on thrombospondin-1-related antireceptor strategies in cancer.
Thrombospondin-1 (TSP-1) is a large matricellular glycoprotein known to be overexpressed within tumor stroma in several cancer types. While mainly considered as an endogenous angiogenesis inhibitor, TSP-1 exhibits multifaceted functionalities in a tumor context depending both on TSP-1 concentration...
Main Authors: | Albin eJEANNE, Christophe eSCHNEIDER, Laurent eMARTINY, Stéphane eDedieu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2015-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fphar.2015.00252/full |
Similar Items
-
Interactions moléculaires TSP1 : CD47 : identification de nouveaux antagonistes à visée thérapeutique
by: Jeanne, Albin
Published: (2013) -
Thrombospondin-1 Receptor CD47 Overexpression Contributes to P-Glycoprotein-Mediated Multidrug Resistance Against Doxorubicin in Thyroid Carcinoma FTC-133 Cells
by: Marie-Pierre Courageot, et al.
Published: (2020-12-01) -
Diabetes Impairs Angiogenesis and Induces Endothelial Cell Senescence by Up-Regulating Thrombospondin-CD47-Dependent Signaling
by: Milad S. Bitar
Published: (2019-02-01) -
Thrombospondin-1/CD47 Interaction Regulates Th17 and Treg Differentiation in Psoriasis
by: Pedro Rodríguez-Jiménez, et al.
Published: (2019-06-01) -
Endothelial Cell Behavior Is Determined by Receptor Clustering Induced by Thrombospondin-1
by: Verônica Morandi, et al.
Published: (2021-03-01)